APO Research
Talk to an analyst

APO RESEARCH · REPORT

E2 Antibody

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global E2 Antibody Industry Growth and Trends Forecast to 2032

19 December 2025112 pages

Choose your research edition.

Industry ResearchE2 Antibody Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal E2 Antibody Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal E2 Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E2 Antibody Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal E2 Antibody Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global E2 Antibody market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for E2 Antibody is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of E2 Antibody include Thermo Fisher Scientific, Merck, United States Biological, Boster Biological Technology, Sino Biological, Santa Cruz Biotechnology, Proteintech, Miltenyi Biotec and LSBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global E2 Antibody market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The E2 Antibody market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global E2 Antibody market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to E2 Antibody.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global E2 Antibody market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

E2 Antibody Market by Company

Thermo Fisher Scientific

Merck

United States Biological

Boster Biological Technology

Sino Biological

Santa Cruz Biotechnology

Proteintech

Miltenyi Biotec

LSBio

ImmuQuest

HUABIO

G Biosciences

FineTest

Creative Diagnostics

Creative Biolabs

Bethyl

Aviva Systems Biology

Abnova

Abcam

E2 Antibody Segment by Type

Polyclonal

Monoclonal

E2 Antibody Segment by Application

Western Blot

Enzyme Linked Immunosorbent Assay

Immunofluorescence

Others

E2 Antibody Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E2 Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E2 Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E2 Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of E2 Antibody manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of E2 Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Polyclonal Table 2. Major Company of Monoclonal Table 3. Global E2 Antibody Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global E2 Antibody Sales by Type (2021-2026) & (Kg) Table 5. Global E2 Antibody Sales Market Share in Volume by Type (2021-2026) Table 6. Global E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 7. Global E2 Antibody Sales Market Share in Value by Type (2021-2026) Table 8. Global E2 Antibody Price by Type (2021-2026) & (US$/Kg) Table 9. Global E2 Antibody Sales by Type (2027-2032) & (Kg) Table 10. Global E2 Antibody Sales Market Share in Volume by Type (2027-2032) Table 11. Global E2 Antibody Sales by Type (2027-2032) & (US$ Million) Table 12. Global E2 Antibody Sales Market Share in Value by Type (2027-2032) Table 13. Global E2 Antibody Price by Type (2027-2032) & (US$/Kg) Table 14. North America E2 Antibody Sales by Type (2021-2026) & (Kg) Table 15. North America E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 16. Europe E2 Antibody Sales by Type (2021-2026) & (Kg) Table 17. Europe E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific E2 Antibody Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America E2 Antibody Sales by Type (2021-2026) & (Kg) Table 21. Latin America E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa E2 Antibody Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa E2 Antibody Sales by Type (2021-2026) & (US$ Million) Table 24. E2 Antibody Industry Trends Table 25. E2 Antibody Industry Drivers Table 26. E2 Antibody Industry Opportunities and Challenges Table 27. E2 Antibody Industry Restraints Table 28. Global E2 Antibody Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global E2 Antibody Revenue Market Share by Company (2021-2026) Table 30. Global E2 Antibody Sales by Company (2021-2026) & (Kg) Table 31. Global E2 Antibody Sales Share by Company (2021-2026) Table 32. Global E2 Antibody Market Price by Company (2021-2026) & (US$/Kg) Table 33. Global E2 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global E2 Antibody Major Company Production Sites and Headquarters Table 35. Global E2 Antibody Company, Product Type & Application Table 36. Global E2 Antibody Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global E2 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global E2 Antibody Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global E2 Antibody Sales by Region (2021-2026) & (Kg) Table 41. Global E2 Antibody Sales Market Share in Volume by Region (2021-2026) Table 42. Global E2 Antibody Sales by Region (2021-2026) & (US$ Million) Table 43. Global E2 Antibody Sales Market Share in Value by Region (2021-2026) Table 44. Global E2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Global E2 Antibody Sales by Region (2027-2032) & (Kg) Table 46. Global E2 Antibody Sales Market Share in Volume by Region (2027-2032) Table 47. Global E2 Antibody Sales by Region (2027-2032) & (US$ Million) Table 48. Global E2 Antibody Sales Market Share in Value by Region (2027-2032) Table 49. Global E2 Antibody Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2027-2032) Table 50. Global E2 Antibody Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global E2 Antibody Sales by Application (2021-2026) & (Kg) Table 52. Global E2 Antibody Sales Market Share in Volume by Application (2021-2026) Table 53. Global E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 54. Global E2 Antibody Sales Market Share in Value by Application (2021-2026) Table 55. Global E2 Antibody Price by Application (2021-2026) & (US$/Kg) Table 56. Global E2 Antibody Sales by Application (2027-2032) & (Kg) Table 57. Global E2 Antibody Sales Market Share in Volume by Application (2027-2032) Table 58. Global E2 Antibody Sales by Application (2027-2032) & (US$ Million) Table 59. Global E2 Antibody Sales Market Share in Value by Application (2027-2032) Table 60. Global E2 Antibody Price by Application (2027-2032) & (US$/Kg) Table 61. North America E2 Antibody Sales by Application (2021-2026) & (Kg) Table 62. North America E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 63. Europe E2 Antibody Sales by Application (2021-2026) & (Kg) Table 64. Europe E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific E2 Antibody Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America E2 Antibody Sales by Application (2021-2026) & (Kg) Table 68. Latin America E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa E2 Antibody Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa E2 Antibody Sales by Application (2021-2026) & (US$ Million) Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific E2 Antibody Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Merck E2 Antibody Product Portfolio Table 80. Merck Recent Development Table 81. United States Biological Company Information Table 82. United States Biological Business Overview Table 83. United States Biological E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. United States Biological E2 Antibody Product Portfolio Table 85. United States Biological Recent Development Table 86. Boster Biological Technology Company Information Table 87. Boster Biological Technology Business Overview Table 88. Boster Biological Technology E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Boster Biological Technology E2 Antibody Product Portfolio Table 90. Boster Biological Technology Recent Development Table 91. Sino Biological Company Information Table 92. Sino Biological Business Overview Table 93. Sino Biological E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Sino Biological E2 Antibody Product Portfolio Table 95. Sino Biological Recent Development Table 96. Santa Cruz Biotechnology Company Information Table 97. Santa Cruz Biotechnology Business Overview Table 98. Santa Cruz Biotechnology E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Santa Cruz Biotechnology E2 Antibody Product Portfolio Table 100. Santa Cruz Biotechnology Recent Development Table 101. Proteintech Company Information Table 102. Proteintech Business Overview Table 103. Proteintech E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Proteintech E2 Antibody Product Portfolio Table 105. Proteintech Recent Development Table 106. Miltenyi Biotec Company Information Table 107. Miltenyi Biotec Business Overview Table 108. Miltenyi Biotec E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Miltenyi Biotec E2 Antibody Product Portfolio Table 110. Miltenyi Biotec Recent Development Table 111. LSBio Company Information Table 112. LSBio Business Overview Table 113. LSBio E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. LSBio E2 Antibody Product Portfolio Table 115. LSBio Recent Development Table 116. ImmuQuest Company Information Table 117. ImmuQuest Business Overview Table 118. ImmuQuest E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. ImmuQuest E2 Antibody Product Portfolio Table 120. ImmuQuest Recent Development Table 121. HUABIO Company Information Table 122. HUABIO Business Overview Table 123. HUABIO E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. HUABIO E2 Antibody Product Portfolio Table 125. HUABIO Recent Development Table 126. G Biosciences Company Information Table 127. G Biosciences Business Overview Table 128. G Biosciences E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 129. G Biosciences E2 Antibody Product Portfolio Table 130. G Biosciences Recent Development Table 131. FineTest Company Information Table 132. FineTest Business Overview Table 133. FineTest E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 134. FineTest E2 Antibody Product Portfolio Table 135. FineTest Recent Development Table 136. Creative Diagnostics Company Information Table 137. Creative Diagnostics Business Overview Table 138. Creative Diagnostics E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 139. Creative Diagnostics E2 Antibody Product Portfolio Table 140. Creative Diagnostics Recent Development Table 141. Creative Biolabs Company Information Table 142. Creative Biolabs Business Overview Table 143. Creative Biolabs E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 144. Creative Biolabs E2 Antibody Product Portfolio Table 145. Creative Biolabs Recent Development Table 146. Bethyl Company Information Table 147. Bethyl Business Overview Table 148. Bethyl E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 149. Bethyl E2 Antibody Product Portfolio Table 150. Bethyl Recent Development Table 151. Aviva Systems Biology Company Information Table 152. Aviva Systems Biology Business Overview Table 153. Aviva Systems Biology E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 154. Aviva Systems Biology E2 Antibody Product Portfolio Table 155. Aviva Systems Biology Recent Development Table 156. Abnova Company Information Table 157. Abnova Business Overview Table 158. Abnova E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 159. Abnova E2 Antibody Product Portfolio Table 160. Abnova Recent Development Table 161. Abcam Company Information Table 162. Abcam Business Overview Table 163. Abcam E2 Antibody Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 164. Abcam E2 Antibody Product Portfolio Table 165. Abcam Recent Development Table 166. North America E2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. North America E2 Antibody Sales by Country (2021-2026) & (Kg) Table 168. North America E2 Antibody Sales Market Share by Country (2021-2026) Table 169. North America E2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 170. North America E2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 171. North America E2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America E2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 173. North America E2 Antibody Market Share by Country (2021-2026) Table 174. North America E2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America E2 Antibody Market Share Forecast by Country (2027-2032) Table 176. Europe E2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Europe E2 Antibody Sales by Country (2021-2026) & (Kg) Table 178. Europe E2 Antibody Sales Market Share by Country (2021-2026) Table 179. Europe E2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 180. Europe E2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 181. Europe E2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe E2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe E2 Antibody Market Share by Country (2021-2026) Table 184. Europe E2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe E2 Antibody Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific E2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific E2 Antibody Sales by Country (2021-2026) & (Kg) Table 188. Asia-Pacific E2 Antibody Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific E2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 190. Asia-Pacific E2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific E2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific E2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific E2 Antibody Market Share by Country (2021-2026) Table 194. Asia-Pacific E2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific E2 Antibody Market Share Forecast by Country (2027-2032) Table 196. Latin America E2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 197. Latin America E2 Antibody Sales by Country (2021-2026) & (Kg) Table 198. Latin America E2 Antibody Sales Market Share by Country (2021-2026) Table 199. Latin America E2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 200. Latin America E2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America E2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America E2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America E2 Antibody Market Share by Country (2021-2026) Table 204. Latin America E2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America E2 Antibody Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa E2 Antibody Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa E2 Antibody Sales by Country (2021-2026) & (Kg) Table 208. Middle East and Africa E2 Antibody Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa E2 Antibody Sales Forecast by Country (2027-2032) & (Kg) Table 210. Middle East and Africa E2 Antibody Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa E2 Antibody Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa E2 Antibody Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa E2 Antibody Market Share by Country (2021-2026) Table 214. Middle East and Africa E2 Antibody Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa E2 Antibody Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. E2 Antibody Distributors List Table 219. E2 Antibody Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. E2 Antibody Image Figure 2. Global E2 Antibody Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E2 Antibody Market Size (2021-2032) & (US$ Million) Figure 4. Global E2 Antibody Sales (2021-2032) & (Kg) Figure 5. Polyclonal Image Figure 6. Global Polyclonal Sales YoY Growth (2021-2032) & (Kg) Figure 7. Monoclonal Image Figure 8. Global Monoclonal Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global E2 Antibody Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global E2 Antibody Market Share by Type 2025 VS 2032 Figure 11. North America E2 Antibody Sales Market Share in Volume by Type in 2025 Figure 12. North America E2 Antibody Sales Market Share in Value by Type in 2025 Figure 13. Europe E2 Antibody Sales Market Share in Volume by Type in 2025 Figure 14. Europe E2 Antibody Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific E2 Antibody Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific E2 Antibody Sales Market Share in Value by Type in 2025 Figure 17. Latin America E2 Antibody Sales Market Share in Volume by Type in 2025 Figure 18. Latin America E2 Antibody Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa E2 Antibody Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa E2 Antibody Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 E2 Antibody Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Western Blot Image Figure 24. Global Western Blot Sales YoY Growth (2021-2032) & (Kg) Figure 25. Enzyme Linked Immunosorbent Assay Image Figure 26. Global Enzyme Linked Immunosorbent Assay Sales YoY Growth (2021-2032) & (Kg) Figure 27. Immunofluorescence Image Figure 28. Global Immunofluorescence Sales YoY Growth (2021-2032) & (Kg) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global E2 Antibody Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global E2 Antibody Market Share by Application 2025 VS 2032 Figure 33. North America E2 Antibody Sales Market Share in Volume by Application in 2025 Figure 34. North America E2 Antibody Sales Market Share in Value by Application in 2025 Figure 35. Europe E2 Antibody Sales Market Share in Volume by Application in 2025 Figure 36. Europe E2 Antibody Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific E2 Antibody Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific E2 Antibody Sales Market Share in Value by Application in 2025 Figure 39. Latin America E2 Antibody Sales Market Share in Volume by Application in 2025 Figure 40. Latin America E2 Antibody Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa E2 Antibody Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa E2 Antibody Sales Market Share in Value by Application in 2025 Figure 43. North America E2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America E2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America E2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America E2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe E2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe E2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe E2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe E2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific E2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific E2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific E2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific E2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America E2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America E2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America E2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America E2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa E2 Antibody Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa E2 Antibody Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa E2 Antibody Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa E2 Antibody Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. E2 Antibody Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. E2 Antibody Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Polyclonal
  • Monoclonal
Applications
  • Western Blot
  • Enzyme Linked Immunosorbent Assay
  • Immunofluorescence
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Merck
  • United States Biological
  • Boster Biological Technology
  • Sino Biological
  • Santa Cruz Biotechnology
  • Proteintech
  • Miltenyi Biotec
  • LSBio
  • ImmuQuest
  • HUABIO
  • G Biosciences
  • FineTest
  • Creative Diagnostics
  • Creative Biolabs
  • Bethyl
  • Aviva Systems Biology
  • Abnova
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global E2 Antibody Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global E2 Antibody Sales Estimates and Forecasts (2021-2032)
  5. 1.3 E2 Antibody Market by Type
  6. 1.3.1 Polyclonal
  7. 1.3.2 Monoclonal
  8. 1.4 Global E2 Antibody Market Size by Type
  9. 1.4.1 Global E2 Antibody Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global E2 Antibody Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global E2 Antibody Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America E2 Antibody Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe E2 Antibody Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific E2 Antibody Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America E2 Antibody Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa E2 Antibody Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 E2 Antibody Industry Trends
  2. 2.2 E2 Antibody Industry Drivers
  3. 2.3 E2 Antibody Industry Opportunities and Challenges
  4. 2.4 E2 Antibody Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by E2 Antibody Revenue (2021-2026)
  2. 3.2 Global Top Players by E2 Antibody Sales (2021-2026)
  3. 3.3 Global Top Players by E2 Antibody Price (2021-2026)
  4. 3.4 Global E2 Antibody Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global E2 Antibody Major Company Production Sites & Headquarters
  6. 3.6 Global E2 Antibody Company, Product Type & Application
  7. 3.7 Global E2 Antibody Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global E2 Antibody Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 E2 Antibody Players Market Share by Revenue in 2025
  11. 3.8.3 2025 E2 Antibody Tier 1, Tier 2, and Tier 3
4 E2 Antibody Regional Status and Outlook
  1. 4.1 Global E2 Antibody Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global E2 Antibody Historic Market Size by Region
  3. 4.2.1 Global E2 Antibody Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global E2 Antibody Sales in Value by Region (2021-2026)
  5. 4.2.3 Global E2 Antibody Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global E2 Antibody Forecasted Market Size by Region
  7. 4.3.1 Global E2 Antibody Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global E2 Antibody Sales in Value by Region (2027-2032)
  9. 4.3.3 Global E2 Antibody Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 E2 Antibody by Application
  1. 5.1 E2 Antibody Market by Application
  2. 5.1.1 Western Blot
  3. 5.1.2 Enzyme Linked Immunosorbent Assay
  4. 5.1.3 Immunofluorescence
  5. 5.1.4 Others
  6. 5.2 Global E2 Antibody Market Size by Application
  7. 5.2.1 Global E2 Antibody Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global E2 Antibody Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global E2 Antibody Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America E2 Antibody Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe E2 Antibody Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific E2 Antibody Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America E2 Antibody Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa E2 Antibody Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific E2 Antibody Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck E2 Antibody Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 United States Biological
  14. 6.3.1 United States Biological Company Information
  15. 6.3.2 United States Biological Business Overview
  16. 6.3.3 United States Biological E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 United States Biological E2 Antibody Product Portfolio
  18. 6.3.5 United States Biological Recent Developments
  19. 6.4 Boster Biological Technology
  20. 6.4.1 Boster Biological Technology Company Information
  21. 6.4.2 Boster Biological Technology Business Overview
  22. 6.4.3 Boster Biological Technology E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Boster Biological Technology E2 Antibody Product Portfolio
  24. 6.4.5 Boster Biological Technology Recent Developments
  25. 6.5 Sino Biological
  26. 6.5.1 Sino Biological Company Information
  27. 6.5.2 Sino Biological Business Overview
  28. 6.5.3 Sino Biological E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sino Biological E2 Antibody Product Portfolio
  30. 6.5.5 Sino Biological Recent Developments
  31. 6.6 Santa Cruz Biotechnology
  32. 6.6.1 Santa Cruz Biotechnology Company Information
  33. 6.6.2 Santa Cruz Biotechnology Business Overview
  34. 6.6.3 Santa Cruz Biotechnology E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Santa Cruz Biotechnology E2 Antibody Product Portfolio
  36. 6.6.5 Santa Cruz Biotechnology Recent Developments
  37. 6.7 Proteintech
  38. 6.7.1 Proteintech Company Information
  39. 6.7.2 Proteintech Business Overview
  40. 6.7.3 Proteintech E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Proteintech E2 Antibody Product Portfolio
  42. 6.7.5 Proteintech Recent Developments
  43. 6.8 Miltenyi Biotec
  44. 6.8.1 Miltenyi Biotec Company Information
  45. 6.8.2 Miltenyi Biotec Business Overview
  46. 6.8.3 Miltenyi Biotec E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Miltenyi Biotec E2 Antibody Product Portfolio
  48. 6.8.5 Miltenyi Biotec Recent Developments
  49. 6.9 LSBio
  50. 6.9.1 LSBio Company Information
  51. 6.9.2 LSBio Business Overview
  52. 6.9.3 LSBio E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LSBio E2 Antibody Product Portfolio
  54. 6.9.5 LSBio Recent Developments
  55. 6.10 ImmuQuest
  56. 6.10.1 ImmuQuest Company Information
  57. 6.10.2 ImmuQuest Business Overview
  58. 6.10.3 ImmuQuest E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ImmuQuest E2 Antibody Product Portfolio
  60. 6.10.5 ImmuQuest Recent Developments
  61. 6.11 HUABIO
  62. 6.11.1 HUABIO Company Information
  63. 6.11.2 HUABIO Business Overview
  64. 6.11.3 HUABIO E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HUABIO E2 Antibody Product Portfolio
  66. 6.11.5 HUABIO Recent Developments
  67. 6.12 G Biosciences
  68. 6.12.1 G Biosciences Company Information
  69. 6.12.2 G Biosciences Business Overview
  70. 6.12.3 G Biosciences E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 G Biosciences E2 Antibody Product Portfolio
  72. 6.12.5 G Biosciences Recent Developments
  73. 6.13 FineTest
  74. 6.13.1 FineTest Company Information
  75. 6.13.2 FineTest Business Overview
  76. 6.13.3 FineTest E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 FineTest E2 Antibody Product Portfolio
  78. 6.13.5 FineTest Recent Developments
  79. 6.14 Creative Diagnostics
  80. 6.14.1 Creative Diagnostics Company Information
  81. 6.14.2 Creative Diagnostics Business Overview
  82. 6.14.3 Creative Diagnostics E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Creative Diagnostics E2 Antibody Product Portfolio
  84. 6.14.5 Creative Diagnostics Recent Developments
  85. 6.15 Creative Biolabs
  86. 6.15.1 Creative Biolabs Company Information
  87. 6.15.2 Creative Biolabs Business Overview
  88. 6.15.3 Creative Biolabs E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Creative Biolabs E2 Antibody Product Portfolio
  90. 6.15.5 Creative Biolabs Recent Developments
  91. 6.16 Bethyl
  92. 6.16.1 Bethyl Company Information
  93. 6.16.2 Bethyl Business Overview
  94. 6.16.3 Bethyl E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bethyl E2 Antibody Product Portfolio
  96. 6.16.5 Bethyl Recent Developments
  97. 6.17 Aviva Systems Biology
  98. 6.17.1 Aviva Systems Biology Company Information
  99. 6.17.2 Aviva Systems Biology Business Overview
  100. 6.17.3 Aviva Systems Biology E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Aviva Systems Biology E2 Antibody Product Portfolio
  102. 6.17.5 Aviva Systems Biology Recent Developments
  103. 6.18 Abnova
  104. 6.18.1 Abnova Company Information
  105. 6.18.2 Abnova Business Overview
  106. 6.18.3 Abnova E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Abnova E2 Antibody Product Portfolio
  108. 6.18.5 Abnova Recent Developments
  109. 6.19 Abcam
  110. 6.19.1 Abcam Company Information
  111. 6.19.2 Abcam Business Overview
  112. 6.19.3 Abcam E2 Antibody Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Abcam E2 Antibody Product Portfolio
  114. 6.19.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America E2 Antibody Sales by Country
  2. 7.1.1 North America E2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America E2 Antibody Sales by Country (2021-2026)
  4. 7.1.3 North America E2 Antibody Sales Forecast by Country (2027-2032)
  5. 7.2 North America E2 Antibody Market Size by Country
  6. 7.2.1 North America E2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America E2 Antibody Market Size by Country (2021-2026)
  8. 7.2.3 North America E2 Antibody Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe E2 Antibody Sales by Country
  2. 8.1.1 Europe E2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe E2 Antibody Sales by Country (2021-2026)
  4. 8.1.3 Europe E2 Antibody Sales Forecast by Country (2027-2032)
  5. 8.2 Europe E2 Antibody Market Size by Country
  6. 8.2.1 Europe E2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe E2 Antibody Market Size by Country (2021-2026)
  8. 8.2.3 Europe E2 Antibody Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific E2 Antibody Sales by Country
  2. 9.1.1 Asia-Pacific E2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific E2 Antibody Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific E2 Antibody Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific E2 Antibody Market Size by Country
  6. 9.2.1 Asia-Pacific E2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific E2 Antibody Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific E2 Antibody Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America E2 Antibody Sales by Country
  2. 10.1.1 South America E2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America E2 Antibody Sales by Country (2021-2026)
  4. 10.1.3 South America E2 Antibody Sales Forecast by Country (2027-2032)
  5. 10.2 South America E2 Antibody Market Size by Country
  6. 10.2.1 South America E2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America E2 Antibody Market Size by Country (2021-2026)
  8. 10.2.3 South America E2 Antibody Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa E2 Antibody Sales by Country
  2. 11.1.1 Middle East and Africa E2 Antibody Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa E2 Antibody Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa E2 Antibody Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa E2 Antibody Market Size by Country
  6. 11.2.1 Middle East and Africa E2 Antibody Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa E2 Antibody Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa E2 Antibody Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 E2 Antibody Value Chain Analysis
  2. 12.1.1 E2 Antibody Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 E2 Antibody Production Mode & Process
  7. 12.2 E2 Antibody Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 E2 Antibody Distributors
  10. 12.2.3 E2 Antibody Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst